What’s Propelling ICU Medical, Inc. (ICUI) to Reach 52-Week High?

June 17, 2018 - By Winifred Garcia

ICU Medical, Inc. (NASDAQ:ICUI) Logo

Investors sentiment is 1.19 in 2018 Q1. Its the same as in 2017Q4. It has no change, as 22 investors sold ICU Medical, Inc. shares while 81 reduced holdings. only 58 funds opened positions while 65 raised stakes. 14.47 million shares or 4.83% less from 15.21 million shares in 2017Q4 were reported.
Deutsche Bankshares Ag stated it has 0.01% of its portfolio in ICU Medical, Inc. (NASDAQ:ICUI). Ellington Management Group Inc Ltd Liability invested in 1,900 shares. Susquehanna Intll Llp invested in 1,367 shares. California Pub Employees Retirement Systems holds 0.01% or 26,447 shares in its portfolio. Moreover, Eagle Boston Inv has 0.02% invested in ICU Medical, Inc. (NASDAQ:ICUI) for 817 shares. Profund Advisors Ltd Company reported 1,729 shares. Moreover, Waddell & Reed has 0.04% invested in ICU Medical, Inc. (NASDAQ:ICUI) for 75,600 shares. 28,280 are owned by Lyon Street Cap Ltd Llc. First Advsr Lp holds 0.01% or 19,831 shares in its portfolio. First Citizens Comml Bank And Trust has invested 0.04% in ICU Medical, Inc. (NASDAQ:ICUI). Moreover, Castleark Management has 0.57% invested in ICU Medical, Inc. (NASDAQ:ICUI) for 71,312 shares. 14,285 were reported by Dixon Hubard Feinour & Brown Va. Panagora Asset Management has invested 0% of its portfolio in ICU Medical, Inc. (NASDAQ:ICUI). Gemmer Asset Mngmt Limited Liability has invested 0.01% in ICU Medical, Inc. (NASDAQ:ICUI). Texas Permanent School Fund stated it has 0.03% in ICU Medical, Inc. (NASDAQ:ICUI).

Since January 4, 2018, it had 0 buys, and 12 selling transactions for $41.35 million activity. LOPEZ GEORGE A had sold 26,475 shares worth $6.53M on Monday, April 2. SAUCEDO JOSEPH R sold $421,285 worth of stock. Shares for $134,925 were sold by Sanzone Virginia Ruth on Tuesday, May 15. 724 shares were sold by SWINNEY ROBERT S, worth $170,140 on Friday, January 19. 1,763 ICU Medical, Inc. (NASDAQ:ICUI) shares with value of $482,480 were sold by Woolson Daniel.

The stock of ICU Medical, Inc. (NASDAQ:ICUI) hit a new 52-week high and has $326.37 target or 6.00 % above today’s $307.90 share price. The 8 months bullish chart indicates low risk for the $6.25 billion company. The 1-year high was reported on Jun, 17 by Barchart.com. If the $326.37 price target is reached, the company will be worth $375.12M more.
The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers come in. During such notable technical setup, fundamental investors usually stay away and are careful shorting or selling the stock.

The stock decreased 0.60% or $1.85 during the last trading session, reaching $307.9. About 156,115 shares traded or 30.93% up from the average. ICU Medical, Inc. (NASDAQ:ICUI) has risen 73.35% since June 17, 2017 and is uptrending. It has outperformed by 60.78% the S&P500.

Analysts await ICU Medical, Inc. (NASDAQ:ICUI) to report earnings on August, 8. They expect $1.70 EPS, up 226.92 % or $1.18 from last year’s $0.52 per share. ICUI’s profit will be $34.52M for 45.28 P/E if the $1.70 EPS becomes a reality. After $2.06 actual EPS reported by ICU Medical, Inc. for the previous quarter, Wall Street now forecasts -17.48 % negative EPS growth.

More notable recent ICU Medical, Inc. (NASDAQ:ICUI) news were published by: Schaeffersresearch.com which released: “Dow Futures Higher With ECB, Retail Sales in the Spotlight” on June 14, 2018, also Benzinga.com with their article: “Benzinga’s Daily Biotech Pulse: Clinical Hold For Crispr, Gilead Study Meets Endpoint, Akers Gets Grace Time” published on June 01, 2018, Streetinsider.com published: “ICU Medical (ICUI) Gains as Smith Group Confirms Early Merger Talks” on May 29, 2018. More interesting news about ICU Medical, Inc. (NASDAQ:ICUI) were released by: Bizjournals.com and their article: “Smiths in talks to merge Minnesota-based medical-device business with California company” published on May 29, 2018 as well as Benzinga.com‘s news article titled: “Benzinga’s Daily Biotech Pulse: Hematology Conference In The Spotlight, Dr. Reddy To Launch Generic Opioid …” with publication date: June 15, 2018.

ICU Medical, Inc. develops, manufactures, and sells medical devices used in infusion therapy, critical care, and oncology applications worldwide. The company has market cap of $6.25 billion. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patientÂ’s vein for use in hospitals and ambulatory clinics. It has a 93.59 P/E ratio. The companyÂ’s infusion therapy products include needlefree connector products, such as MicroClave and MicroClave Clear, Neutron, NanoClave, Clave, and SwabCap; custom infusion sets; and Tego needlefree hemodialysis connectors.

ICU Medical, Inc. (NASDAQ:ICUI) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.